Michael Shevlin

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

647

H-Index

1

About

Dr. Michael Shevlin is a leading figure in the field of synthetic chemistry, with a distinguished focus on high-throughput experimentation and automated reaction development. His most impactful contribution is the pioneering of nanomole-scale high-throughput chemistry, a transformative approach that enables the rapid synthesis and optimization of complex molecules using vanishingly small amounts of material. This work, detailed in his highly cited 2014 paper (647 citations), has revolutionized early-stage drug discovery and natural product synthesis by allowing researchers to scout hundreds of reaction conditions in parallel, dramatically accelerating timelines while conserving precious substrates. By miniaturizing and automating synthetic route scouting, Shevlin has addressed a critical bottleneck in pharmaceutical research, providing a powerful tool for chemists to explore chemical space with unprecedented efficiency. His innovations have made complex molecule synthesis faster, more sustainable, and more accessible, cementing his reputation as a key architect of modern, data-driven synthetic methodology.

Research Focus

Key Achievements

1
H-Index
1
Papers
647
Total Citations
647
Avg Citations/Paper
🏆 Most Cited Paper
Nanomole-scale high-throughput chemistry for the synthesis of complex molecules
647 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago